CHCHD2 is coamplified with EGFR in NSCLC and regulates mitochondrial function and cell migration

Molecular Cancer Research

Volumn 13, Issue 7, 2015, Pages 1119-1129

  Wei, Yuhong ^a   Vellanki, Ravi N ^b,c   Coyaud, Etienne ^c   Ignatchenko, Vladimir ^c   Li, Lei ^a,c   Krieger, Jonathan R ^a   Taylor, Paul ^a   Tong, Jiefei ^a   Pham, Nhu An ^b,c   Liu, Geoffrey ^c,d   Raught, Brian ^c,e   Wouters, Bradly G ^b,c,e   Kislinger, Thomas ^c,e   Tsao, Ming Sound ^b,c,e   Moran, Michael F ^a,c,e  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Campbell Family Institute for Cancer Research   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COILED COIL HELIX COILED COIL HELIX DOMAIN CONTAINING 2 PROTEIN; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; Y BOX BINDING PROTEIN 1; C1QBP PROTEIN, HUMAN; CARRIER PROTEIN; CHCHD2 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEOME; TRANSCRIPTION FACTOR; YBX1 PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; TUMOR XENOGRAFT; UPREGULATION; AFFINITY CHROMATOGRAPHY; BIOLOGY; CELL MOTION; CHROMOSOME 7; GENETICS; LUNG TUMOR; METABOLISM; MITOCHONDRION; TUMOR CELL LINE; XENOGRAFT;

CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMATOGRAPHY, AFFINITY; CHROMOSOMES, HUMAN, PAIR 7; COMPUTATIONAL BIOLOGY; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEOME; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTORS; Y-BOX-BINDING PROTEIN 1;

EID: 84942304049     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0165-T     Document Type: Article

References (57)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30.
2. Wang J, Qian J, Hoeksema MD, Zou Y, Espinosa AV, Rahman SM, et al Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung. Clin Cancer Res 2013; 19:5580-90.
3. The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM). A genomics-based classification of human lung tumors. Sci Transl Med 2013; 5:209ra153.
4. Cardarella S, Johnson BE The impact of genomic changes on treatment of lung cancer. Am J Respir Crit Care Med 2013; 188:770-5.
5. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455:1069-75.
6. Sos ML, Michel K, Zander T, Weiss J, Frommolt P, Peifer M, et al Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 2009; 119:1727-40.
7. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, et al Characterizing the cancer genome in lung adenocarcinoma. Nature 2007; 450: 893-8.
8. Zhu CQ, da Cunha Santos G, Ding K, Sakurada A, Cutz JC, Liu N, et al. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2008; 26: 4268-75.
9. Duffy MJ. The war on cancer: are we winning? Tumour Biol 2013; 34:1275-84.
10. Kao J, Pollack JR RNA interference-based functional dissection of the 17q12 ampliconinbreastcancer reveals contributionofcoamplifiedgenes. Genes Chromosomes Cancer 2006; 45:761-9.
11. Scott D, Elsden J, Pearson A, Lunec J. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? Cancer Lett 2003; 197:81-6.
12. Vogt N, Gibaud A, Almeida A, Ourliac-Garnier I, Debatisse M, Malfoy B. Relationships linking amplification level to gene over-expression in gliomas. PLoS ONE 2010; 5:e14249.
13. Campbell JM, Lockwood WW, Buys TP, Chari R, Coe BP, Lam S, et al Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer. Genome 2008; 51:1032-9.
14. Li L, Wei Y, To C, Zhu CQ, Tong J, Pham NA, et al Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact. Nat Commun 2014; 5:5469.
15. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010; 28:1248-50.
16. An J, Shi J, He Q, Lui K, Liu Y, Huang Y, et al CHCM1/CHCHD6, novel mitochondrial protein linked toregulationofmitofilin and mitochondrial cristae morphology. J Biol Chem 2012; 287:7411-26.
17. Cavallaro G. Genome-wide analysis of eukaryotic twin CX9C proteins. Mol Biosyst 2010; 6:2459-70.
18. Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA, et al ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J Biol Chem 2011; 286:2918-32.
19. Yang J, Staples O, Thomas LW, Briston T, Robson M, Poon E, et al Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression. J Clin Invest 2012; 122:600-11.
20. Baughman JM, Nilsson R, Gohil VM, Arlow DH, Gauhar Z, Mootha VK A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis. PLoS Genet 2009; 5:e1000590.
21. Aras S, Pak O, Sommer N, Finley R Jr, Huttemann M, Weissmann N, et al Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res 2013; 41:2255-66.
22. Seo M, Lee WH, Suk K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J 2010; 24:464-78.
23. Hanahan D, Weinberg RA Hallmarks of cancer: the next generation. Cell 2011; 144:646-74.
24. Tong J, Taylor P, Peterman S, Prakash A, Moran M. EGF receptor phosphorylation sites S991 and Y998 are implicated in the regulation of receptor endocytosis and p38 MAP kinase-dependent phosphorylations at S1039 and T1041. Mol Cell Proteomics 2009; 8:2131-44.
25. Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, Cohen P. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoformsbymitogen-activatedprotein kinase kinase4 (MKK4) and MKK7. Biochem J 2000; 352(Pt 1):145-54.
26. Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE 2013; 8:e64817.
27. Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, et al Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res 2011; 10:161-74.
28. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008; 26:1367-72.
29. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10:1794-805.
30. Roux KJ, Kim DI, Raida M, Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol 2012; 196:801-10.
31. Comartin D, Gupta GD, Fussner E, Coyaud E, Hasegan M, Archinti M, et al CEP120 and SPICE1 cooperate with CPAP in centriole elongation. Curr Biol 2013; 23:1360-6.
32. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010; 26:966-8.
33. Huangda W, Sherman BT, Lempicki RA. Systematic and integrativeanalysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57.
34. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006; 34:D535-9.
35. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498-504.
36. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, et al Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003; 21:3798-807.
37. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4.
38. Tong J, Taylor P, Moran MF Proteomic analysis of the EGFR interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress. Mol Cell Proteomics 2014; 13:1644-58.
39. Choi H, Larsen B, Lin ZY, Breitkreutz A, Mellacheruvu D, Fermin D, et al SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods 2011; 8:70-3.
40. Pierce NW, Lee JE, Liu X, Sweredoski MJ, Graham RL, Larimore EA, et al Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell 2013; 153:206-15.
41. Havugimana PC, Hart GT, Nepusz T, Yang H, Turinsky AL, Li Z, et al A census of human soluble protein complexes. Cell 2012; 150: 1068-81.
42. Tsofack SP, Garand C, Sereduk C, Chow D, Aziz M, Guay D, et al NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines. Mol Cancer 2011; 10:145.
43. Zhang X, Zhang F, Guo L, Wang Y, Zhang P, Wang R, et al Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis. Mol Cell Proteomics 2013; 12:3199-209.
44. Han T, Kang D, Ji D, Wang X, Zhan W, Fu M, et al How does cancer cell metabolism affect tumor migration and invasion? Cell Adh Migr 2013; 7: 395-403.
45. Diers AR, Higdon AN, Ricart KC, Johnson MS, Agarwal A, Kalyanaraman B, et al Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. Biochem J 2010; 426:31-41.
46. Diers AR, Broniowska KA, Chang CF, Hogg N. Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. Biochem J 2012; 444:561-71.
47. Lin L, McCroskery S, Ross JM, Chak Y, Neuhuber B, Daniels MP Induction of filopodia-like protrusions by transmembrane agrin: role of agrin glycosaminoglycan chains and Rho-family GTPases. Exp Cell Res 2010; 316:2260-77.
48. Parker JJ, Dionne KR, Massarwa R, Klaassen M, Foreman NK, Niswander L, et al Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma. Neuro Oncol 2013; 15:1048-57.
49. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448:561-6.
50. Baldi L, Mengoli MC, Bisagni A, Banzi MC, Boni C, Rossi G. Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: report of a case and review of the literature with demonstration of genes alteration into the same tumor cells. Lung Cancer 2014; 86:291-5.
51. Kee Y, Yang K, Cohn MA, Haas W, Gygi SP, D'Andrea AD. WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complex. J Biol Chem 2010; 285:11252-7.
52. Moretti J, Chastagner P, Liang CC, Cohn MA, Israel A, Brou C. The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation. J Biol Chem 2012; 287:29429-41.
53. Li X, Stevens PD, Yang H, Gulhati P, Wang W, Evers BM, et al The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Oncogene 2013; 32:471-8.
54. McGee AM, Douglas DL, Liang Y, Hyder SM, Baines CP The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death. Cell Cycle 2011; 10:4119-27.
55. Lasham A, Print CG, Woolley AG, Dunn SE, Braithwaite AW YB-1: oncoprotein, prognostic marker and therapeutic target? Biochem J 2013; 449:11-23.
56. Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer. Clin Lung Cancer 2012; 13:375-84.
57. Panupinthu N, Yu S, Zhang D, Zhang F, Gagea M, Lu Y, et al Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer. Oncogene 2014; 33:2846-56.